DDD pacing in hypertrophic cardiomyopathy: A multicentre clinical experience

Heart

Volumn 75, Issue 1, 1996, Pages 44-49

  Slade, Alistair K B ^a   Sadoul, Nicolas ^b   Shapiro, Leonard ^c   Chojnowska, Lidia ^d   Simon, Jean Phillippe ^b   Saumarez, Richard C ^a   Dodinot, Bernard ^b   Camm, A John ^a   McKenna, William J ^a   Aliot, Etienne ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITÉ DE LORRAINE   (France)

^c Regional Cardiac Centre   (United Kingdom)

^d INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Dual chamber pacing; Hypertrophic cardiomyopathy; Left ventricular outflow tract obstruction

Indexed keywords

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART PACING; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL;

EID: 9044234767     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.75.1.44     Document Type: Article

References (30)

1. McKenna W, Deanfield J, Faruqui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 1981;47:532-8.
2. Frank MJ, Abdulla AM, Canedo MI, Saylors RE. Long-term medical management of hypertrophic obstructive cardiomyopathy. Am J Cardiol 1978;42:993-1001.
3. Bonow RO, Rosing DR, Bacharach SL, et al. Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation 1981;64:787-96.
4. McIntosh CL, Maron BJ. Current operative treatment of obstructive hypertrophic cardiomyopathy. Circulation 1988;78:487-95.
5. Cooley DA, Wukasch DC, Leachman RD. Mitral valve replacement for idiopathic hypertrophic subaortic stenosis: results in 27 patients. J Cardiovasc Surg (Torino) 1976;17:380-7.
6. McDonald K, McWilliams E, O'Keeffe B, Maurer B. Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy. Eur Heart J 1988;9:893-8.
7. Jeanrenaud X, Goy JJ, Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 1992;339:1318-23.
8. Fananapazir L, Cannon RO, Tripodi D, Panza JA. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation 1992;85:2149-61.
9. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 1981;48:418-28.
10. Sadoul N, Simon JP, de Chillou C, et al. Interets de la stimulation cardiaque permanente dans les myocardiopathies hypertrophiques et obstructives rebelles au traitement medical. Arch Mal Coeur 1994;87:1315-23.
11. Gilgenkrantz J, Cherrier F, Petitier H, Dodinot B, Houplon M, Legoux J. Cardiomyopathie obstructive du ventricle gauche avec block auriculo-ventriculaire complet. Considerations therapeutiques. Arch Mal Coeur 1968;61: 439-53.
12. Hassenstein P, Storch HH, Schmitz W. [Results of electrical pacing in patients with hypertrophic obstruction cardiomyopathy (author's translation)]. Thoraxchir Vask Chir 1975;23:496-8.
13. Duck HJ, Hutschenreiter W, Pankau H, Trenckmann H. [Atrial synchronous ventricular stimulation with reduced a.v. delay time as a therapeutic principle in hypertrophic obstructive cardiomyopathy]. Z Gesamte Inn Med 1984; 39:437-47.
14. Loogen F, Kuhn H, Gietzen F, Losse B, Schulte HD, Bircks W. Clinical course and prognosis of patients with typical and atypical hypertrophic obstructive and with hypertrophic non-obstructive cardiomyopathy. Eur Heart J 1983;4(suppl F):145-53.
15. McKenna WJ, Deanfield JE. Hypertrophic cardiomyopathy: an important cause of sudden death. Arch Dis Child 1984;59:971-5.
16. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAreavey D. Long term results of dual chamber pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994;90:2731-42.
17. Slade AKB, Page C, Jones S, Keeling PJ, McKenna WJ, Camm AJ. Objective assessment of exercise capacity can be utilised to guide implantation and assess improvement after dual chamber pacing in hypertrophic cardiomyopathy [abstract]. PACE 1994;17:744.
18. Redwood DR, Goldstein RE, Hirshfeld J, et al. Exercise performance after septal myotomy and myectomy in patients with obstructive hypertrophic cardiomyopathy. Am J Cardiol 1979;44:215-20.
19. Gras D, De Place C, Le Breton H, et al. L'importance du synchronisme auriculo-ventriculaire dans la cardiomyopathie hypertrophique obstructive traitee par stimulation cardiaque. Arch Mal Coeur 1995;88: 215-23.
20. Jeanrenaud X, Sadoul N, Simon J-P, et al. Multicenter European experience on permanent pacing for hypertrophic obstructive cardiomyopathy (HOCM) [abstract]. Eur Heart J 1993;14:270.
21. Janosik DL, Pearson AC, Buckingham TA, Labovitz AJ, Redd RM. The hemodynamic benefit of differential atrioventricular delay intervals for sensed and paced atrial events during physiologic pacing. J Am Coll Cardiol 1989;14:499-507.
22. Wish M, Fletcher RD, Gottdiener JS, Cohen AI. Importance of left atrial timing in the programming of dual-chamber pacemakers. Am J Cardiol 1987;60: 566-71.
23. Wigle ED, Sasson Z, Henderson MA, et al. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis 1985;28:1-83.
24. Xiao HB, Brecker SJD, Gibson DG. Differing effects of right ventricular pacing and left bundle branch block on left ventricular function. Br Heart J 1993;69: 166-73.
25. Nishimura RA, Danielson GK. Dual chamber pacing for hypertrophic cardiomyopathy: has its time come? Br Heart J 1994;70:301-3.
26. Symanski JD, Nishimura RA, Hayes DL, Tajik AJ. The effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy: an acute Doppler/catheterization hemodynamic study [abstract]. Circulation 1994;90(4) Pt II:654.
27. Betocchi S, Losi MA, Piscione F, et al. Atrio-ventricular pacing relieves obstruction but impairs diastolic function in hypertrophic cardiomyopathy [abstract]. J Am Coll Cardiol 1994;23(suppl A):11.
28. McDonald K, O'Sullivan JJ, King G, Conroy R, Maurer B. Dual chamber pacing improves left ventricular filling in patients with hypertrophic cardiomyopathy [abstract]. Eur Heart J 1989;10(suppl):401.
29. Schulte HD, Bircks WH, Loesse B, Godehardt EA, Schwartzkopff B. Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. Late results up to twenty-five years. J Thorac Cardiovasc Surg 1993;106:709-17.
30. Mohr R, Schaff HV, Danielson GK, Puga FJ, Pluth JR, Tajik AJ. The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy. Experience over 15 years. J Thorac Cardiovasc Surg 1989;97:666-74.